Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO).
Kissei introduces Iktos AI Drug Discovery System
Parkinson's Drug Discovery Collaboration Between Astrogen, Iktos to Leverage AI Platform
Drug Discovery using Artificial Intelligence
Key points to succeed in Artificial Intelligence drug discovery projects
Sygnature Discovery to Deploy Iktos's AI for Makya™ - AI-TechPark
American Chemical Society
Iktos Announces Deployment of their AI for Drug Design Software Makya™ by Chiesi Group - AITechTrend
Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
Iktos, Bayer Use AI to Develop Sustainable Crop Protection Products - Environment+Energy Leader